
PDSB
Pds Biotechnology
$0.69
+$0.01 (+1.76%)Jul 27, 2026
Key metrics
The numbers that frame PDSB today
- Market cap
- $38.68M
- P/E (TTM)
- -1.2
- EV / FCF
- -1.4
- ROIC
- -237.9%
- Div yield
- 0%
- Debt / equity
- 4.1
- 52wk Low
- $0.51
- 52wk High
- $1.55
Growth
Revenue and earnings trend for PDSB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about PDSB
Is Pds Biotechnology a good buy?
No. Pds Biotechnology has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Pds Biotechnology is selling at a very high price.
What is the market capitalization of PDSB?
Pds Biotechnology's market capitalization is $38.68M.
What is the P/E ratio for PDSB stock?
Pds Biotechnology's current P/E ratio is -1.2.
What is the 52-week high for PDSB stock?
The 52-week high for Pds Biotechnology is $1.55. The current close of $0.69 is 55.3% below that high.
What is the 52-week low for PDSB stock?
The 52-week low for Pds Biotechnology is $0.51. The current close of $0.69 is 36.7% above that low.
Does PDSB stock pay dividends?
Pds Biotechnology does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for PDSB?
Pds Biotechnology's Debt / Equity ratio is 4.08.